Skip to main content

Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial



Exercise may improve cardiorespiratory fitness in people with schizophrenia, however, possible condition-specific cardiorespiratory disadvantages, a scarcity of methodologically sound studies, and conflicting results raise questions about the effect of exercise on maximal oxygen uptake (VO2max) in this group. The primary aim of this study, therefore, was to investigate the effect of high-intensity interval training on VO2max in people with schizophrenia. Second, we sought to determine whether the intervention would have an effect on general physical activity (PA) level and body composition.


Eighty-two patients with schizophrenia were randomly assigned to supervised high-intensity interval training or computer gaming skills training, performed twice a week for 12 weeks. Oxygen uptake was measured directly, during a maximum exercise session on a treadmill. PA level were assessed using ActiGraph accelerometer, and body composition was assessed by bioelectrical impedance. Differences between groups were assessed by analysis of variance using a univariate general linear model.


There were no significant differences between the groups on any of the cardiorespiratory variables neither at baseline nor after the program. There were also no significant within-group differences in any of the cardiorespiratory fitness variables between the baseline and post-program time points, despite that 61% of the participants performing high-intensity interval training showed a significant increase in workload on the treadmill. However, 47% of the participants in the high-intensity interval training group had a ≥ 5% increase in VO2max. Participants supervised by mental health care providers with PA competence (e.g. rehabilitation center staff, sport scientist, physical trainer) had a much larger increase in VO2max compared to participants supervised by mental health workers without such competence, and when adding PA competence to the model, the intervention group increased VO2max significantly compared to the comparison group. The intervention had no significant effect on PA level or body composition.


The intervention did not improve VO2max, PA level or body composition but succeeded in increasing workload on the treadmill. With regard to VO2max, approximately half of the patients may be considered responders.

Trial registration; NCT02205684, registered July 2014,

Peer Review reports


The effects of schizophrenia on years of potential life lost and life expectancy are substantial [1]. People with schizophrenia have an elevated risk of developing cardiovascular diseases (CVD) and a significantly increased risk of death from CVD compared to the general population, which may, to a large extent, explain the shortened life expectancy in this patient group [2,3,4]. The prevalence discrepancy in somatic disorders, such as CVD [2] and type 2 diabetes (T2D) [5, 6], between people with schizophrenia and the general population, is not fully understood. It is likely due to a complex interplay among many factors, such as the metabolic side effects of antipsychotics (i.e., leading to overweight) [7], tobacco smoking [8], alcohol misuse [9], poor dietary habits [10], low help-seeking behavior [11] and a possible genetic susceptibility to cardiovascular disease in people with schizophrenia [12, 13]. Additionally, low levels of moderate and vigorous intensity physical activity (MVPA) [14,15,16], excessive amounts of sedentary time [16, 17] (defined as any waking behavior characterized by an energy expenditure ≤1.5 metabolic equivalents while in a seated or reclining posture [18]), and poor cardiorespiratory fitness (CRF) levels [15, 19], have been recognized as potentially important factors for the high prevalence of somatic disorders [20,21,22].

In the general population, CRF levels have been linked to both genetic [23] and behavioral factors, including physical activity (PA) [24] and exercise [25]. The observed low PA level [15] and lack of exercise in people with schizophrenia may, therefore, be important factors explaining the poor CRF level. However, the picture may be more complex in this patient group. It has been proposed that, in addition to adverse metabolic effects, antipsychotic drugs also have adverse effects on the cardiovascular system (i.e., antagonistic activity at alpha-adrenergic receptors) [26,27,28]. It is also proposed that a high prevalence of chronotropic incompetence (attenuated heart rate response to exercise) [26, 29], reduced activity of the efferent vagal system [30] and mitochondrial dysfunction [31, 32] may be condition-specific factors related to their CRF level.

Because people with schizophrenia in general have low CRF level, which is closely linked to CVD and mortality, supporting this patient group to exercise and thereby increasing their CRF level seems appropriate. However, the abovementioned cardiovascular disadvantages may potentially negatively impact the effect of exercise on the cardiorespiratory system. Although one meta-analysis [33] and two systematic reviews [19, 34] all concluded that exercise significantly improves CRF levels in schizophrenia, most of the included studies had methodological shortcomings. For example, of the eight studies included in these papers, four did not include a control group [35,36,37,38], and one was nonrandomized [39]. Furthermore, the number of participants was generally very low, ranging from five to 16 in the exercise group. Finally, none of the studies controlled for physical effort using the respiratory exchange ratio (RER) value or any other possible confounder. Although criteria for what constitutes a valid CRF test were often given, it was not reported how many participants passed the criteria for a valid test. The only study with a relatively large sample size and a relatively rigorous design and analysis found a significant difference between the groups, but this was due to a decline in the CRF of the control group participants rather than increased CRF in the participants of the exercise group [40].

The positive effect of exercise, especially high-intensity interval training (HIIT), on CRF and health is well established in studies of the general population [41] and across several diseases-specific states [42]. Given the abovementioned possible cardiorespiratory disadvantages (e.g. chronotropic incompetence and mitochondrial dysfunction) in people with schizophrenia and conflicting results from the few studies conducted, the effect of exercise on CRF in this patient group is unclear. The primary aim of this study, therefore, was to investigate the effect of HIIT on CRF in people with schizophrenia. Second, we aimed to test whether partaking in an HIIT exercise regime in combination with applying key constructs from social cognitive theory (e.g., self-efficacy and social support for PA) would have an effect on the general PA level; third, we sought to test whether the intervention would have secondary effects on body composition.


Study design

This study is based on data from the Effects of Physical Activity in Psychosis study (EPHAPS) (, registration number NCT02205684). The study was approved by the Regional Ethics Committee for Medical Research (2014/372). The methods used in EPHAPS have been described in detail elsewhere [43]. Briefly, the study was designed as a randomized, controlled, parallel-group, observer-blinded clinical trial with the aim of investigating the effects of a supervised high-intensity interval training program on maximal oxygen uptake (VO2max), cognitive function and psychiatric symptom load in outpatients with schizophrenia.

Recruitment and participants

Participants were recruited from August 2014 through May 2017 from catchment-area-based and publicly funded outpatient psychiatric clinics in Vestfold County, Norway. Patients aged 18–67 years old, IQ ≥ 70, who understood and spoke a Scandinavian language and fulfilled the criteria in The Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) [44] for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder, and schizophreniform disorder) were eligible for the study. Patients who were pregnant or had physical contraindications to exercise were excluded. Initial information about the study was given to eligible patients by clinical staff in the outpatient clinic or in primary health services. Written consent was obtained from those eligible patients who understood the nature of the research and were willing to participate. Eighty-three participants signed the informed consent form and were included in the study. One participant withdrew from the study after baseline testing but before randomization. A scheme of the flow of participants through the trial is presented in Fig. 1.

Fig. 1

EPHAPS trial flowchart

Randomization and stratification

After the baseline assessments, the participants were randomly assigned to either the HIIT group (intervention group) or the computer gaming skills group (comparison group). A computerized random number generator was utilized to produce the allocation sequence. Equal distribution of CRF between the two groups of participants was ensured by stratification around the expected median of baseline VO2max scores. By varying the size of the stratification blocks, we kept each treatment assignment unpredictable. A designated project coordinator, who was not involved in recruitment or measurement sessions, administered the group assignments using the method of concealed envelopes. The randomization process was performed at a site remote from where the intervention took place.


The HIIT sessions and the computer gaming took place at different locations and the participants in the two groups did not have any contact with each other. The same personnel, which were employed in the outpatient clinics and dedicated to the project throughout the intervention period, carried out supervision of the participants in both groups. The time spent with activities was the same in both groups, as was the time spent with the intervention staff. A specific time schedule was followed by the staff to ensure that each session in the exercise and comparison group lasted 45 min. In addition to the sessions, most of the participants in both groups were accompanied by a member of the intervention staff during transportation to and from the sessions. Both groups also received treatment as usual.

The exercise sessions consisted of supervised walking/running on a treadmill twice a week for 12 weeks. The exercise sessions were led by two teams each consisting of two persons. The two different teams had different background and experience with regard to exercise and physical activity. Half of the participants were supervised by mental health care providers with PA competence (rehabilitation center staff with relevant PA education), and the other half was led by mental health professionals without PA competence. Each session had the following structure: an 8-min warm up, followed by 4 × 4 min intervals at 85–95% of maximum heart rate, with active pauses consisting of 3 min of walking/running at approximately 70% of maximum heart rate, and a 5 min cool-down period at the end. Heart rate was measured and controlled continuously throughout the exercise session by the intervention staff to ensure that the participants’ intervals and active pauses were performed with the desired intensity. Peak heart rate from the VO2max test was used to calculate prescribed exercise intensity. Additionally, the intervention staff attempted to increase the participants’ motivation for PA. Although delivered in informal settings, during transportation, and before and after sessions, the motivational work was individualized, structured and theory-based. Key constructs from social cognitive theory [45] were applied: opportunities to perform PA, social support for PA, confidence to engage in PA, expected benefits and costs of performing PA, knowledge and skill to perform PA, and personal goal setting.

Participants in the comparison group took part in sessions in which they performed computer-simulated sports activities, such as tennis, baseball, golf and bowling, on a Nintendo Wii Sports console (Nintendo, Kyoto, Japan). Physiological responses (i.e., oxygen consumption, cardiac output, metabolic rate) to Nintendo Wii tennis and baseball have been shown to be lower than the response to brisk treadmill walking when tested in bouts of 10 min [46].


Cardiorespiratory fitness, or maximal oxygen uptake (VO2max), was assessed through a maximum exercise test on a treadmill (Woodway, Würzburg, Germany), by physical activity professionals, before and after the 12-week intervention. We used a modified Balke protocol [47], where speed was held constant at 5 km∙h− 1 and the inclination angle was increased by one degree every minute until exhaustion within 6–12 min. Gas exchange was continuously sampled in a mixing chamber every 30 s by having the subjects breathe into a Hans Rudolph two-way breathing valve (2700 series, Hans Rudolph Inc., Kansas City, USA). The breathing valve was connected to a Jaeger Oxycon Pro (Erich Jaeger GmbH, Hoechberg, Germany), which was used to analyze the oxygen and carbon dioxide content. The Jaeger Oxycon Pro has been found to be both valid and reliable [48]. The test result was included in the current study if the respiratory exchange ratio (RER) (i.e., physical strain) was ≥1.00 [49]. Heart rate was recorded with an RCX3 heart monitor from Polar (Polar Electro Oy, Kempele, Finland). The oxygen pulse (ml∙beat− 1) was calculated by dividing VO2max (mL∙min− 1) by the maximal heart rate (beats∙ min− 1) and used as an estimate of the heart’s stroke volume.

Pulmonary function was measured by maximal expiratory flow volume curves (MasterScreen Pneumo spirometer; CareFusion, Hochberg, Germany) according to current guidelines set by the American Thoracic Society and The European Respiratory Society in 2005 [50]. The items measured were forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC and maximal expiratory flow at 50% of FVC (MEF 50%). Maximal voluntary ventilation (MVV) was estimated as FEV1 multiplied by 35. In addition, breathing reserve (%) was calculated using the following equation: ([MVV - VEmax]/MVV) × 100, where VEmax is the maximal minute ventilation during the exercise test. Predicted spirometry values were according to [51]. Obstructive lung disease was identified by FEV1/FVC < 0.7 [52].

Physical activity was assessed using the ActiGraph GT3X+ accelerometer (ActiGraph, LLC, Pensacola, FL, USA) in vertical axis collection mode. The participants were instructed to wear the accelerometer over the left hip while awake, except during water-based activities (e.g., showering, swimming), for four consecutive days. The epoch length (sample interval) was set to 10 s. All data were reintegrated into 60 s epochs and further processed and analyzed using specialized accelerometer analytical software (Kinesoft, version 3.3.80, Saskatchewan, Canada). Analyses were restricted to participants who wore the accelerometer for a minimum of 10 h per day [53] for at least two days (including one weekday and one weekend day) [54,55,56]. To identify different intensities of PA, we applied count thresholds corresponding to the energy cost of the given intensity, where sedentary time was defined as all activity < 100 counts per minute (CPM) [57], a threshold that corresponds with sitting, reclining, or lying down. Light intensity PA was defined as 100–2019 CPM, moderate as 2020–5998 CPM, and vigorous as CPM ≥ 5999 [58].

Body composition was estimated barefooted in light clothing by bioelectrical impedance (MC-980 MA; Tanita Corp., Tokyo, Japan). Assessment of body composition was performed around noon, approximately three hours after a light breakfast, at both time points. Weight was measured to the nearest 0.5 kg in light clothing and no shoes using a SECA electronic scale (SECA model 767; Hamburg, Germany). Height was measured without shoes on a portable stadiometer (Harpenden; Holtain, Crymych, Wales) and rounded to the nearest 0.5 cm.

Data on education, employment, marital status and smoking were obtained through a clinical interview and the use of hospital charts. Positive and negative psychotic symptom levels, as well as the total general symptom level were assessed with the Positive and Negative Syndrome Scale (PANSS) [59]. Information on current medication was acquired through patients’ interviews and the use of medical records and information from the general practitioners. Defined daily doses (DDD) were calculated in accordance with guidelines from the World Health Organization Collaborating Center for Drug Statistics Methodology ( The DDD is the assumed average maintenance dose per day for a drug used for its main indication on adults and provide a fixed unit of measurement independent of dosage form, providing a rough estimate of pharmaceutical drugs consumption.

Statistical analysis

All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences for Windows, version 24, IBM, Inc., Chicago, IL, USA). Descriptive data are presented as proportions, means, and standard deviations (SDs) with 95% confidence intervals (CIs) where appropriate. Within- and between-group differences in interval data were evaluated by t-tests (independent t-tests and paired t-tests). Differences between groups were assessed by analysis of variance using a univariate general linear model. Baseline CRF variables (dependent variables) were adjusted for RER, age and sex (covariates). Post-program CRF variables were adjusted for post-program RER, age and sex. After the completion of our trial, Firth et al. (2017) showed in a meta-analysis that exercise studies that were supervised by PA professionals (e.g. rehabilitation center staff, sport scientist, physical trainer) were more effective [60]. Our study was not designed or powered to look at staff competence, but present explorative analysis of time x group x staff PA competence, using a three-way repeated measures ANOVA. A univariate general linear model was used to assess differences between the groups PA level (CPM, sedentary time, light intensity PA, moderate intensity PA, vigorous intensity PA and steps per day). Accelerometer wear time was considered a potential confounder and included in the analysis. Differences between the groups in terms of education level, employment and marital status were assessed using chi-squared tests. Treadmill speed and/or inclination on interval number three in weeks four and 12 was analyzed to estimate progress or work capacity. For work capacity, week four was set as baseline measure to avoid a learning effect on the treadmill. All significance tests were two-sided.


Table 1 displays the relevant demographic and clinical information for both groups. Except for three participants, all were using antipsychotic medication. Sixty-two participants used second-generation antipsychotics (SGA) and six used first-generation antipsychotics (FGA). Of the 25 participants receiving ≥ two different antipsychotic drugs, 11 received a combination of FGA and SGA. There were no significant differences between groups with respect to type of antipsychotic medication and the main metabolic risk profile of these drugs [61, 62]. Defined daily doses of antipsychotics was slightly higher in the intervention group compared to the comparison group (mean diff 0.4, 95% CI 0.0, 0.8; P = 0.04). There were no other statistical differences between the groups at baseline. In addition, regular antidepressants, mood stabilizing medication and anxiolytics were received by 19, 12 and 11 participants, respectively.

Table 1 Baseline sociodemographic and clinical characteristics for both groups

Of the 43 participants randomized to HIIT, 34 (79%) attended the post-program measurements and 21 (49%) had a valid VO2max test (Fig. 1). Of the 39 participants randomized to the comparison group, 37 (95%) attended the post-program measurements and 26 (67%) had a valid VO2max test (Fig. 1).

There were no differences between groups in any of the cardiorespiratory variables either at baseline or after the program (Table 2). There were no within-group differences in any of the cardiorespiratory fitness variables between the baseline and post-program time points. However, 47% of the participants in the intervention group and 27% in the comparison group had a ≥ 5% increase in VO2max (mL∙kg− 1∙min− 1). We classified participants with ≥1 metabolic equivalent (MET) increase in VO2max (mL∙kg− 1∙min− 1) as responders [63]. The responders had, adjusted for gender, significantly lower VO2max at baseline (mean diff. -8.4 mL∙kg− 1∙min− 1, 95% CI -15, − 1.4; P = 0.02) were 7.7 (14, 0.4; P = 0.03) years older and had higher BMI (4.0 kg∙m− 2, 0.5, 7.6; P = 0.02), waist circumference (11 cm 21, 1.4; P = 0.02) and visceral fat mass (5.5 kg, 8.5, 2.6; P < 0.0001) than non-responders (<5% increase in VO2max (mL∙kg− 1∙min− 1). No other differences were found between responders and non-responders, including exercise performance (number of sessions, number of intervals, number of intervals above 85% of maximum heart rate).

Table 2 Between-group difference in cardiorespiratory responses to maximal exercise at baseline and post-program

The HIIT participants led by mental health workers with PA competence had a significantly larger increase in CRF (2.4 mL∙kg− 1∙min− 1 ± 4.5) compared to the HIIT participants led by mental health workers without such competence (− 2.2 mL∙kg− 1∙min− 1 ± 4.7), with a mean difference of 4.7 mL∙kg− 1∙min− 1 (95% CI = 1.2, 8,1; P = 0.010). There were no significant differences in number of sessions, number of intervals or number of intervals performed at ≥85% of maximal heart rate between the two HIIT groups. So, when controlling for staff PA competence there was a significant difference in CRF between the intervention group and the comparison group (F [1, 60] = 11.4, p = 0.001; Wilk’s Λ = 0.84, partial ƞ2 = 0.16).

The average number of sessions conducted was 18.1 ± 4.3 and 19.2 ± 2.0 (mean diff − 1.1, 95% CI -2.6, 0.4; P = 0.16) in the intervention and comparison groups, respectively, and participation ranged from 6 to 24 sessions in the intervention group and 15 to 24 in the comparison group. In the intervention group, 83% of the participants attended ≥60% of the sessions, and 54% attended ≥80% of the sessions. In the comparison group, 100 and 70% attended ≥60% and ≥ 80% of the sessions, respectively. There was no significant difference in any of the cardiorespiratory variables after we excluded those who participated in either <60% or <80% of the sessions. Of a possible total of 96 intervals, the exercise group conducted, on average, 69 ± 19 intervals (range 16 to 96). 39.9% of the intervals was performed ≥85% of maximal heart rate. There was no significant correlation between VO2max and the number of intervals performed. However, there was a significant correlation (r = 0.43; P = 0.14) between number of intervals performed at ≥85% of maximum heart rate and change in VO2max.

Participants in the exercise group showed significant improvements in work capacity, shown by both improved treadmill running speed and inclination from week four to week 12 (Table 3). Sixty-one percent improved running speed and/or inclination. Eighty-six percent of the responders (≥ 1MET increase in VO2max), compared to 53% of the non-responders (< 1 MET increase in VO2max) improved work capacity (P = 0.50). Ninety percent of the participants achieved ≥85% of maximum heart rate during both exercise sessions.

Table 3 Work capacity measured at interval number three in weeks 4 and 12 in the group performing high-intensity interval training

There were no differences in pulmonary function between groups or within groups at either time point (Table 4). Baseline VO2max (mL∙kg− 1∙min− 1) had a moderate correlation with FVC (r = 0.31, P = 0.01), FEV1 (r = 0.35, P < 0.001) and MEF50 (r = 0.40, P < 0.01). Twelve percent had < 80% of predicted FEV1, and 10.5% scored below 70% on the FEV1/FVC ratio (FEV1%). Thirty percent had a low breathing reserve (< 15%), whereas 32% had a high breathing reserve (> 40%) that may suggest pulmonary or cardiovascular limitations, respectively, for exercise performance [64].

Table 4 Between-group differences in pulmonary function at baseline and post-program

There were no significant differences between the groups in PA level or sedentary time at either time point (Table 5). No statistical changes were found within groups in any of the PA or sedentary variables. There were no associations between changes in VO2max and any of the PA variables.

Table 5 Between-group differences in physical activity level and sedentary time at baseline and post-program

There were no significant differences in body composition between groups at either time point (Table 6). No statistically significant changes were found within groups in any of the body composition variables.

Table 6 Between-group difference in weight, BMI, waist circumference and body composition at baseline and post-program


This is the largest study to date investigating the effects of HIIT in schizophrenia, compared with with low intensity game-based exercise. We managed in the current study to recruit patients with schizophrenia into a highly physically demanding exercise program. Most of the participants adhered to the exercise protocol in terms of both the number and the intensity of the sessions. The intervention group did not significantly improve their VO2max, and no significant difference between the groups was found after the program, even when we excluded those that did not adhere to the exercise protocol. However, approximately half of the participants responded satisfactory (increased VO2max with ≥1 MET) to the intervention. The intervention group, especially the responders, did increase their work capacity, as shown by the increased workload on the treadmill (i.e. speed and/or inclination). When controlling for PA competence among intervention staff in explorative analysis, the intervention group significantly increased VO2max compared to the comparison group. The intervention did not have any effect on the PA level, sedentary behavior or body composition of the participants.

Although there were no significant within- or between-group differences, almost half of the participants in the intervention group had 5 % or greater increase in VO2max. The participants who responded (i.e., with increased VO2max) to the exercise regime did not differ from the non-responders with respect to the quantity or quality of training conducted, but we did find a correlation between change in VO2max and number of intervals performed at ≥85% of maximum heart rate. Importantly, the responders had a lower VO2max and were heavier and older than the non-responder at baseline, and thus an especially important target group within this population. Our results may imply that people with schizophrenia can respond as expected to HIIT but that there may be more non-responders in this patient group than in the general population [65]. If our results hold true, we need to further investigate why some patients do not respond to HIIT to see if measures can be taken (e.g., medication) and perhaps to a larger extent treating underlying pulmonary and cardiovascular diseases affecting normal physiological adaptation to exercise.

Regarding the effect of HIIT on VO2max in this patient group, the literature is not consistent. The EPHAPS study reinforces the uncertainty of whether this patient group as a whole responds as expected to this type of training. As mentioned in the introduction, there might be condition-specific and medication-related factors hindering their ability to adapt normally to HIIT and thus preventing the physiological adaptations necessary to increase VO2max.

One of the possible benefits of HIIT is an improvement of VO2max, and thus involves several organs. VO2max is primarily limited by the ability of the cardiorespiratory system to deliver oxygen to the exercising muscle [66]. This means that, theoretically, one would need to make adaptations related to the heart’s stroke volume in order to increase VO2max. Thus, one possible explanation for the lack of effect on VO2max, although measured indirectly, might be the fact that the participants’ stroke volume did not increase. There might also be other plausible reasons for the lack of effect, such as the high prevalence of abnormal breathing reserve (indicating pulmonary or heart disease) and a relatively high prevalence of cardiovascular and respiratory disease. Furthermore, in a systematic review including 35 studies using population-based samples, 97 genes were found to predict VO2max trainability, and lower responders had fewer positive response alleles than higher responders [67]. Thus, one could imagine that people with schizophrenia have fewer positive response alleles than other populations, or that potential epigenetic modifiers, such as medication, sleep, and body fat, influence gene expression and molecular function, thereby influencing VO2max training response [67].

As discussed above, there might be several reasons for the lack of significant effect on VO2max. The most plausible reason however, may coincide with the exercise regime per se. The total exercise volume (number of sessions per week, number of intervals per session, intensity) and/or the number of participants adhering to the protocol might have been insufficient to obtain a significant effect on VO2max. The significant correlation between number of intervals performed ≥85% of maximal heart rate and improvements in VO2max supports the view that the exercise intensity, on a group level, might have been too low on too many intervals. The exercise protocol in the current study, however, is widely used, with success, in different populations and should have been sufficient to obtain positive results [41, 42], moreover, most of the participants adhered to the strictly supervised sessions, both in terms of number of intervals and intensity. Furthermore, a recently published study on people with schizophrenia, using exactly the same exercise protocol, with fewer participants than in our study, did find a significant effect on VO2max in the exercise group compared to a control group [68].

There was a markedly difference in response to the intervention with regard to CRF improvement within the HIIT group. The subgroup supervised by mental health care providers with PA competence had a significant increase in CRF, while the subgroup supervised by mental health care providers without such competence did not. We did not find any differences with regard to adherence to the exercise protocol between the two subgroups, but this may be due to lack of statistical power and/or validity of training diaries. These analyses were done post hoc, based on the findings by Firth et al. (2017), which found that the effect of exercise was larger among patients supervised by PA professionals [60]. Half of our participants were supervised by PA professionals and when adding PA competence to the model there was a significant increase in CRF in the intervention group compared to the comparison group. We do not have data to explain this result and can only speculate if our main results would have been different if all participants were supervised by health care providers with PA competence.

The intervention did not change the participants’ total PA level. Performing HIIT twice a week was probably enough of a challenge for the participants, and a “light-touch” PA component designed to increase motivation for PA was not grasped. Furthermore, the lack of improved body composition is in line with previous research [33]. An improvement in body composition would probably demand both an increased total PA level and an adapted diet [69].

The EPHAPS study has a number of strengths. First, we were able to recruit a large number of patients into a methodologically rigorous RCT involving a highly physical demanding exercise protocol, designed to increase VO2max, and a sound comparison condition. The broad recruitment strategies and wide inclusion criteria markedly strengthen the generalizability of the results. Second, each exercise session was carefully supervised by skilled personnel, who most likely contributed considerably to the number of patients who fulfilled the relatively demanding exercise requirements (i.e., number of sessions and intensity of intervals). Other major strengths of this study included direct measurement of VO2max and stricter conditions than previous research for what constitutes a valid result, objective measurement of PA levels, and reliable measurement of body composition and pulmonary function. One major weakness affecting the power of the study was the high number of invalid VO2max tests. Although most of the patients exerted maximum effort during the VO2max test, many did not manage to achieve a respiratory exchange ratio of ≥1.00 and hence failed to attain a valid test result.


The intervention did not improve maximal oxygen uptake, physical activity level or body composition but succeeded in increasing work capacity. With regard to maximal oxygen uptake, approximately half of the participants may be considered responders. Although most of the participants adhered to the exercise protocol, the correlation between number of intervals performed ≥85% of maximal heart rate with improvement in VO2max, leaves some uncertainty of whether an even stricter intensity-supervision would have yielded different results. Further investigation is needed to determine why so many did not respond to the exercise regime and to identify the consequences of non-response. HIIT is a demanding exercise protocol, especially for patients with severe mental disorders, who may benefit from supervision of health care providers with competence on physical activity rather than health care providers without such competence.

Availability of data and materials

Data can be accessed upon request.



cardiovascular disease


type 2 diabetes


moderate- and vigorous intensity physical activity


cardiorespiratory fitness


physical activity


respiratory exchange ratio


high-intensity interval training


effects of physical activity in psychosis study

VO2max :

maximal oxygen uptake


forced vital capacity

FEV1 :

forced expiratory volume in 1 s

MEF 50%:

maximal expiratory flow 50%


maximal voluntary ventilation


defined daily doses


second generation antipsychotics


first generation antipsychotics


metabolic equivalent


positive and negative syndrome scale


fat free mass


confidence interval


standard deviation


breathing reserve


counts per minute


body mass index


  1. 1.

    Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301.

    PubMed  Google Scholar 

  2. 2.

    Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–80.

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    Nielsen RE, Uggerby AS, Jensen SO, McGrath JJ. Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades--a Danish nationwide study from 1980 to 2010. Schizophr Res. 2013;146(1–3):22–7.

    PubMed  Google Scholar 

  4. 4.

    Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. 2013;346:f2539.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Stubbs B, Vancampfort D, De Hert M, Mitchell AJ. The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand. 2015;132(2):144–57.

    CAS  PubMed  Google Scholar 

  6. 6.

    Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–74.

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123(2–3):225–33.

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606–10.

    CAS  PubMed  Google Scholar 

  9. 9.

    Hjorthoj C, Ostergaard ML, Benros ME, Toftdahl NG, Erlangsen A, Andersen JT, et al. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study. Lancet Psychiatry. 2015;2(9):801–8.

    PubMed  Google Scholar 

  10. 10.

    Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res. 2013;47(2):197–207.

    PubMed  Google Scholar 

  11. 11.

    Fleury MJ, Grenier G, Bamvita JM, Caron J. Professional service utilisation among patients with severe mental disorders. BMC Health Serv Res. 2010;10:141.

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92(2):197–209.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Malan-Muller S, Kilian S, van den Heuvel LL, Bardien S, Asmal L, Warnich L, et al. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia. Schizophr Res. 2016;170(1):1–17.

    PubMed  Google Scholar 

  14. 14.

    Stubbs B, Firth J, Berry A, Schuch FB, Rosenbaum S, Gaughran F, et al. How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res. 2016;176(2–3):431–40.

    PubMed  Google Scholar 

  15. 15.

    Andersen E, Holmen TL, Egeland J. Martinsen EW. Bang-Kittilsen G, et al. Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample. Schizophr Res: Bigseth TT; 2018.

    Google Scholar 

  16. 16.

    Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–15.

    PubMed  PubMed Central  Google Scholar 

  17. 17.

    Janney CA, Ganguli R, Richardson CR, Holleman RG, Tang G, Cauley JA, et al. Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST study). Schizophr Res. 2013;145(1–3):63–8.

    PubMed  Google Scholar 

  18. 18.

    Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, Latimer-Cheung AE, et al. Sedentary behavior research network (SBRN) - terminology consensus project process and outcome. Int J Behav Nutr Phys Act. 2017;14(1):75.

    PubMed  PubMed Central  Google Scholar 

  19. 19.

    Vancampfort D, Rosenbaum S, Probst M, Soundy A, Mitchell AJ, De Hert M, et al. Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis. Acta Psychiatr Scand. 2015;132(2):131–43.

    CAS  PubMed  Google Scholar 

  20. 20.

    Vancampfort D, De Hert M, Sweers K, De Herdt A, Detraux J, Probst M. Diabetes, physical activity participation and exercise capacity in patients with schizophrenia. Psychiatry Clin Neurosci. 2013;67(6):451–6.

    PubMed  Google Scholar 

  21. 21.

    Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr Psychiatry. 2012;53(7):1028–33.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry. 2009;194(6):491–9.

    PubMed  Google Scholar 

  23. 23.

    Bouchard C, An P, Rice T, Skinner JS, Wilmore JH, Gagnon J, et al. Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study. J Appl Physiol (1985). 1999;87(3):1003–8.

  24. 24.

    Nokes N. Relationship between physical activity and aerobic fitness. J Sports Med Phys Fitness. 2009;49(2):136–41.

    CAS  PubMed  Google Scholar 

  25. 25.

    Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2015;4(7).

  26. 26.

    Kim DD, Lang DJ, Procyshyn RM, Woodward ML, Kaufman K, White RF, et al. Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia. Psychiatry Res. 2018;262:28–33.

    CAS  PubMed  Google Scholar 

  27. 27.

    Piascik MT, Perez DM. Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther. 2001;298(2):403–10.

    CAS  PubMed  Google Scholar 

  28. 28.

    Hermesh H, Shiloh R, Epstein Y, Manaim H, Weizman A, Munitz H. Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs. Am J Psychiatry. 2000;157(8):1327–9.

    CAS  PubMed  Google Scholar 

  29. 29.

    Herbsleb M, Schumann A, Malchow B. Puta C. Gabriel HW, et al. Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophrenia. Schizophr Res: Schulze PC; 2018.

    Google Scholar 

  30. 30.

    Ostermann S, Herbsleb M, Schulz S, Donath L, Berger S, Eisentrager D, et al. Exercise reveals the interrelation of physical fitness, inflammatory response, psychopathology, and autonomic function in patients with schizophrenia. Schizophr Bull. 2013;39(5):1139–49.

    PubMed  Google Scholar 

  31. 31.

    Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry. 2011;26(1):45–56.

    CAS  PubMed  Google Scholar 

  32. 32.

    Rosenfeld M, Brenner-Lavie H, Ari SG, Kavushansky A, Ben-Shachar D. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol Psychiatry. 2011;69(10):980–8.

    CAS  PubMed  Google Scholar 

  33. 33.

    Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45(7):1343–61.

    CAS  PubMed  Google Scholar 

  34. 34.

    Vancampfort D, Rosenbaum S, Ward PB, Stubbs B. Exercise improves cardiorespiratory fitness in people with schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2015;169(1–3):453–7.

    PubMed  Google Scholar 

  35. 35.

    Strassnig MT, Newcomer JW, Harvey PD. Exercise improves physical capacity in obese patients with schizophrenia: pilot study. Schizophr Res. 2012;141(2–3):284–5.

    PubMed  Google Scholar 

  36. 36.

    Bredin SS, Warburton DE, Lang DJ. The health benefits and challenges of exercise training in persons living with schizophrenia: a pilot study. Brain Sci. 2013;3(2):821–48.

    PubMed  PubMed Central  Google Scholar 

  37. 37.

    Rosenbaum S, Lagopoulos J, Curtis J, Taylor L, Watkins A, Barry BK, et al. Aerobic exercise intervention in young people with schizophrenia spectrum disorders; improved fitness with no change in hippocampal volume. Psychiatry Res. 2015;232(2):200–1.

    PubMed  Google Scholar 

  38. 38.

    Dodd KJ, Duffy S, Stewart JA, Impey J, Taylor N. A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study. Disabil Rehabil. 2011;33(13–14):1222–9.

    PubMed  Google Scholar 

  39. 39.

    Heggelund J, Nilsberg GE, Hoff J, Morken G, Helgerud J. Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial. Nord J Psychiatry. 2011;65(4):269–75.

    PubMed  PubMed Central  Google Scholar 

  40. 40.

    Scheewe TW, Takken T, Kahn RS, Cahn W, Backx FJ. Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia. Med Sci Sports Exerc. 2012;44(10):1834–42.

    PubMed  Google Scholar 

  41. 41.

    Cassidy S, Thoma C, Houghton D, Trenell MI. High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia. 2017;60(1):7–23.

    PubMed  Google Scholar 

  42. 42.

    Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014;48(16):1227–34.

    PubMed  Google Scholar 

  43. 43.

    Engh JA, Andersen E, Holmen TL, Martinsen EW, Mordal J, Morken G, et al. Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. Trials. 2015;16:557.

    PubMed  PubMed Central  Google Scholar 

  44. 44.

    AmericanPsychiatricAssociation. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub. 2013.

  45. 45.

    Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143–64.

    PubMed  Google Scholar 

  46. 46.

    Willems M, Bond T. Comparison of physiological and metabolic responses to playing Nintendo Wii sports and brisk treadmill walking. J Human Kinet. 2009;22:43–50.

    Google Scholar 

  47. 47.

    Balke B, Ware RW. An experimental study of physical fitness of air force personnel. U S Armed Forces Med J. 1959;10(6):675–88.

    CAS  PubMed  Google Scholar 

  48. 48.

    Carter J, Jeukendrup AE. Validity and reliability of three commercially available breath-by-breath respiratory systems. Eur J Appl Physiol. 2002;86(5):435–41.

    PubMed  Google Scholar 

  49. 49.

    Howley ET, Bassett DR Jr, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc. 1995;27(9):1292–301.

    CAS  PubMed  Google Scholar 

  50. 50.

    Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.

    CAS  Google Scholar 

  51. 51.

    Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.

    PubMed  PubMed Central  Google Scholar 

  52. 52.

    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.

    CAS  PubMed  Google Scholar 

  53. 53.

    Wolff-Hughes DL, Bassett DR, Fitzhugh EC. Population-referenced percentiles for waist-worn accelerometer-derived total activity counts in U.S. youth: 2003–2006 NHANES. PLoS One. 2014;9(12):e115915.

  54. 54.

    Hart TL, Swartz AM, Cashin SE, Strath SJ. How many days of monitoring predict physical activity and sedentary behaviour in older adults? Int J Behav Nutr Phys Act. 2011;8:62.

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr. Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc. 2002;34(8):1376–81.

    PubMed  Google Scholar 

  56. 56.

    Rowe DA, Kemble CD, Robinson TS, Mahar MT. Daily walking in older adults: day-to-day variability and criterion-referenced validity of total daily step counts. J Phys Act Health. 2007;4(4):434–46.

    PubMed  Google Scholar 

  57. 57.

    Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, et al. Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidemiol. 2008;167(7):875–81.

    PubMed  PubMed Central  Google Scholar 

  58. 58.

    Troiano RP. A timely meeting: objective measurement of physical activity. Med Sci Sports Exerc. 2005;37(11 Suppl):S487–9.

    PubMed  Google Scholar 

  59. 59.

    Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.

    CAS  PubMed  Google Scholar 

  60. 60.

    Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, et al. Aerobic exercise improves cognitive functioning in people with schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2017;43(3):546–56.

    PubMed  Google Scholar 

  61. 61.

    Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119–36.

    PubMed  PubMed Central  Google Scholar 

  62. 62.

    Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–47.

    PubMed  PubMed Central  Google Scholar 

  63. 63.

    Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.

    PubMed  PubMed Central  Google Scholar 

  64. 64.

    Wasserman K, Hansen J, Sue D, Stringer W, Whipp B. Principles of exercise testing and interpretation. 5 ed: Lippincott Williams & Wilkins; 2012.

  65. 65.

    Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33(6 Suppl):S446–51; discussion S52–3.

  66. 66.

    Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32(1):70–84.

    PubMed  Google Scholar 

  67. 67.

    Williams CJ, Williams MG, Eynon N, Ashton KJ, Little JP, Wisloff U, et al. Genes to predict VO2max trainability: a systematic review. BMC Genomics. 2017;18(Suppl 8):831.

    PubMed  PubMed Central  Google Scholar 

  68. 68.

    Brobakken MF, Nygard M, Guzey IC, Morken G, Reitan SK, Heggelund J, et al. Aerobic interval training in standard treatment of out-patients with schizophrenia: a randomized controlled trial. Acta Psychiatr Scand. 2019;140(6):498–507.

    CAS  PubMed  Google Scholar 

  69. 69.

    Beavers KM, Beavers DP, Nesbit BA, Ambrosius WT, Marsh AP, Nicklas BJ, et al. Effect of an 18-month physical activity and weight loss intervention on body composition in overweight and obese older adults. Obesity (Silver Spring). 2014;22(2):325–31.

    Google Scholar 

Download references


The authors would like to give thanks to all participants. The authors also thanks Ole-Jakob Bredrup, Helge Bjune, Jan-Freddy Hovland, Bjørn-Einar Oscarsen, Camilla Lahn-Johannessen and Ellen Gurine Færvik for conducting the measurements and delivering the intervention.


The main study (EPHAPS) has received funding from Vestfold Hospital Trust, South-Eastern Norway Regional Health Authority, Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds, Norwegian Research network in Severe Mental Illness (NORSMI), NORMENT/KG Jebsen Center for Psychosis Research, Torgeir Lindvik’s Trust, and Civitan International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information




Conceptualization: EA, JAE, JE, GBK, TTB, TLH, EWM and TS. Data curation: EA, JAE, JE, GBK and TS. Formal analysis: EA, JAE, GBK and TS. Investigation: EA, JAE, JE, GBK, TTB, TLH, EWM and TS. Writing – original draft: EA. Writing – review and editing: EA, JAE, JE, GBK, TTB, TLH, EWM and TS. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Eivind Andersen.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Regional Ethics Committee for Medical Research, REC south east Norway (2014/372). Initial information about the study was given to eligible patients by clinical staff in the outpatient clinic or in primary health services. Written consent was obtained from those eligible patients who understood the nature of the research and were willing to participate.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Andersen, E., Bang-Kittilsen, G., Bigseth, T.T. et al. Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial. BMC Psychiatry 20, 425 (2020).

Download citation


  • Schizophrenia
  • RCT
  • Exercise
  • Maximal oxygen uptake
  • Physical activity